Triverus helps pre-commercial Biotech wrapped in approval delays, co-promotion demands and acquisition from a global pharmaceutical company.
Ready. Set. Stop! A pre-commercial biotech company faced delays in FDA approval for nearly a year, derailing plans to launch their first drug. As anticipated approval finally approached, the company had less than six months to regear for the launch. They now faced new challenges and complexity: they needed to re-engage vendors and navigate a new co-promotion deal with a global pharmaceutical partner. With contractual obligations, tight timelines and limited resources, the biotech was in urgent need of support.
Triverus was engaged to program manage all IT enablement activities and help execute a successful launch. Leveraging extensive knowledge provisioning key business and IT capabilities needed for launch and their associated implementation timelines, Triverus used its proven launch methodology and approach to:
Adding to the complexity of the initiative, the biotech was acquired by the global pharmaceutical company five months after launch. Triverus continued providing support for all the acquisition knowledge transfer and information exchange activities.
After partnering with Triverus’ experienced Life Sciences team, the biotech had all critical business and IT capabilities ready for launch:
Finally, post launch, all commercial workstreams transitioned knowledge smoothly to their counterpart in the global pharmaceutical organization.
Are your business and IT capabilities ready for your next launch? Connect with our team.